I’m pleased to introduce you to the August issue of Multiple Myeloma Updates for Advanced Practitioners in Oncology.
We’re fortunate to have a host of treatment options for our patients, who will likely relapse several times during their MM journey. But how do we determine the best course of treatment at relapse, and how do we assure patients that they are indeed receiving the best therapy for their particular situation?
Today I’d like to ask you to watch Chapter 7 from our video roundtable discussion, which focuses on just that: choosing the right treatment for the right patient. Watch the whole video to hear the complete panel discussion.
To help you stay informed, I've gathered some links to MM articles recently published in the peer-reviewed literature, as well as some more news items from the ASCO Annual Meeting in Chicago.
As always, feel free to share this MM resource, the video roundtable discussion, and the JADPRO supplement with your colleagues.
Beth Faiman, PhD, APN-BC, AOCN®
Multiple Myeloma Program
Taussig Cancer Institute